2H-Benzimidazol-2-one, 1,3-dihydro-1-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-
| Title | Journal |
|---|---|
| Flibanserin: First Global Approval. | Drugs 20151001 |
| Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder. | CNS spectrums 20150201 |
| The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice. | Journal of neural transmission (Vienna, Austria : 1996) 20121101 |
| An update on the pharmacological management of female sexual dysfunction. | Expert opinion on pharmacotherapy 20121001 |
| Population pharmacokinetic/pharmacodynamic model for the sedative effects of flibanserin in healthy volunteers. | Pharmaceutical research 20120601 |
| Resurgence of interest in sexual dysfunction? | BJU international 20120601 |
| Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study. | The journal of sexual medicine 20120401 |
| Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study. | The journal of sexual medicine 20120301 |
| Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality. | The journal of sexual medicine 20120301 |
| Isolation and structural elucidation of flibanserin as an adulterant in a health supplement used for female sexual performance enhancement. | Journal of pharmaceutical and biomedical analysis 20120105 |
| Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease. | Journal of neural transmission (Vienna, Austria : 1996) 20111201 |
| Satisfying sexual events as outcome measures in clinical trial of female sexual dysfunction. | The journal of sexual medicine 20111201 |
| Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial. | The journal of sexual medicine 20111101 |
| [Depressive disorder, treatment and sexual dysfunction--part II]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20111001 |
| Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women. | The journal of sexual medicine 20110501 |
| Multifunctional pharmacology of flibanserin: possible mechanism of therapeutic action in hypoactive sexual desire disorder. | The journal of sexual medicine 20110101 |
| Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness. | Molecular brain 20110101 |
| Pharmacogenetics of antidepressants. | Frontiers in pharmacology 20110101 |
| Consultation corner. The latest on female sexual health. | The Johns Hopkins medical letter health after 50 20101101 |
| [The abandonment of the development of flibanserin]. | Revue medicale suisse 20101027 |
| Boehringer Ingelheim withdraws libido drug for women. | BMJ (Clinical research ed.) 20101012 |
| Do drugs have a role in turning indifference into passion? | BMJ (Clinical research ed.) 20101005 |
| Flibanserin: initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder. | The journal of sexual medicine 20101001 |
| [When women complain about lacking libido. The problem with the desire]. | MMW Fortschritte der Medizin 20100902 |
| Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20100901 |
| Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women. | Women's health (London, England) 20100901 |
| Dysfunctional women remain unsexed. | BJU international 20100801 |
| [Normality of the female libido? (2)]. | Revue medicale suisse 20100714 |
| Drug for low sexual desire carries significant harms, FDA advisers find. | BMJ (Clinical research ed.) 20100707 |
| [Normality of the female libido (1)]. | Revue medicale suisse 20100630 |
| Flibanserin, a drug intended for treatment of hypoactive sexual desire disorder in pre-menopausal women, affects spontaneous motor activity and brain neurochemistry in female rats. | Naunyn-Schmiedeberg's archives of pharmacology 20100601 |
| FDA advisers to assess drug for low sexual desire in women. | BMJ (Clinical research ed.) 20100525 |
| Acute and repeated flibanserin administration in female rats modulates monoamines differentially across brain areas: a microdialysis study. | The journal of sexual medicine 20100501 |
| Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test. | Pharmacology, biochemistry, and behavior 20100501 |
| Modifying 5-HT1A Receptor Gene Expression as a New Target for Antidepressant Therapy. | Frontiers in neuroscience 20100101 |
| Management of hypoactive sexual desire disorder in women: current and emerging therapies. | International journal of women's health 20100101 |
| A new strategy for antidepressant prescription. | Frontiers in neuroscience 20100101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20090501 |
| Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells. | The international journal of neuropsychopharmacology 20080501 |
| High-efficacy 5-HT1A agonists for antidepressant treatment: a renewed opportunity. | Journal of medicinal chemistry 20071004 |
| Redistribution of the water channel protein aquaporin-4 and the K+ channel protein Kir4.1 differs in low- and high-grade human brain tumors. | Acta neuropathologica 20050401 |
| Association of the C(-1019)G 5-HT1A functional promoter polymorphism with antidepressant response. | The international journal of neuropsychopharmacology 20041201 |
| Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine. | The Journal of pharmacy and pharmacology 20040101 |
| Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors. | British journal of pharmacology 20030801 |
| Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain. | The international journal of neuropsychopharmacology 20020601 |
| Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. | Pharmaceutical research 20020301 |
| Pharmacology of flibanserin. | CNS drug reviews 20020101 |
| Mechanism of action of flibanserin in the learned helplessness paradigm in rats. | European journal of pharmacology 20011214 |
| Further characterisation of potential antidepressant action of flibanserin. | Psychopharmacology 20011201 |
| Lack of interaction between flibanserin and antidepressants in inducing serotonergic syndrome in rats. | The international journal of neuropsychopharmacology 20010301 |
| Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors. | Pharmacological research 20010201 |
| Anti-anhedonic actions of the novel serotonergic agent flibanserin, a potential rapidly-acting antidepressant. | European journal of pharmacology 19971211 |